Aortech Share Discussion Threads

[nextlink] 12/9/2018 12:37

Given the rise on moderate volume, maybe a few
delayed buys out there.

[someuwin] 12/9/2018 12:21

Can't even get a buy quote for £1k now.

[volsung] 12/9/2018 12:03

Back in today. Hopefully a nice rise from here

[davisc5] 12/9/2018 10:47

Nice slow Burner today

[someuwin] 12/9/2018 10:35

All this for just £11m? Too cheap on any measure...

"AorTech owns, what the Board believes to be, a valuable IP portfolio covering a family of medical grade polymers (Elast-Eon(TM) ) and a number of medical devices. Its polymers are fully approved for long term human implants and over 4 million patients' lives are dependent on devices enabled by Elast-Eon(TM). To date, approximately GBP60 million, in aggregate, has been invested in developing the Company's polymer technology and in its heart valve designs and testing."

[someuwin] 12/9/2018 09:11

Yeah - even tighter now.

They'll have to move it up soon.

[davisc5] 12/9/2018 09:04

Good job someone can ?

[someuwin] 12/9/2018 08:36

Limits are tight. Can currently buy £1k online. But not £2k.

[greedy rooster] 11/9/2018 15:05

Scope for these to end 75-80 by the end of the day.

[langland] 11/9/2018 13:18

Today should be a turn day IMO and we should rally till last week of OCT. So let's see. I could only buy 5k just now.

[someuwin] 11/9/2018 13:07

For the first time in a while you can sell more than you can buy.

Max online buy quote now £5k.

[bones] 11/9/2018 13:04

Decent nibbling this morning. I guess there is some supply of stock coming from the open offer 30p shares but I have tested the quotes today and there's not too much available without putting in a limit price.

[bones] 11/9/2018 13:02

Yes, GR, I would agree about possible update on implants given the recent granting of US and Brazilian patents for the necessary technology. I imagine AOR will have given the patent offices a kick a while back to hurry those along given they were originally filed in 2016.US and Brazil being the top two markets would suggest there's plenty to fight for, especially with so many cowboys in the space!

[greedy rooster] 11/9/2018 11:44

Nice parallel channels developing on pull backs - similar to movement around the start of the year. From a chart perspective, shouldn't be long until the next spike upwards. I reckon we'll get something on the breast implants and an update on grafts/bores before end of year.

[someuwin] 11/9/2018 08:49

And AOR is less than £11m.

...At the moment.

[blueball] 11/9/2018 08:11

I agree 100p will be the stop when it turns.

VRS is a £250mill co incredible.

[zoro9791] 11/9/2018 07:57

It's good if the narrative turns out be true. So far the management looks like a decent kind but like I said this is AIM where directors gets wealthy and PIs get burnt.

[zoro9791] 11/9/2018 07:54

Yes I respect that I'll wait till the end of the year than see what's happen.

[ny boy] 11/9/2018 07:49

I doubt many are buying these because of a 400p broker note that could be achieved at sometime in the future. They are buying because of the enormous potential and quantity of management.

I am adding on decent pull backs as we rise towards triple figures, 100p is the first target, it’s following a similar pattern to VRS

Will add more as and when, happy with progress so far, it’s a 2-5 year hold for me and if the Company performs well a longer term hold.

[bones] 10/9/2018 19:46

Each to their own strategies, Zoro.

[zoro9791] 10/9/2018 19:42

I appoliges it's my bad than I misunderstood something.The kind of " not having mine " comments always make me smile. I have seen May times this kind and for me is an alarm bell.Lost to much on AIM shares so I rather be carefull if it comes to that I cut loss and move on. Two years is long time to wait for any AIM share in my opinion.

[bones] 10/9/2018 19:08

Zoro, 400p was never forecast for end 2018. That is totally misleading.

I can only urge investors to subscribe for the broker note (which was published in June 2018) but in any case the little excerpt in the header gives you the context of the 400p target. It is loaded with caveats but suggests, if success shows up, the target is likely to prove conservative. Broker targets are not time-stamped guarantees.

In particular, the note says that this is a 2 year strategy and, ONLY IF the company achieves its development aims and actually manages to commercialise the products will the 400p be realistic.

What Stockdale have said is they will update their note after the interim results are published in December 2018 and progress is weighed up at that time.

[zoro9791] 10/9/2018 16:15

Don't have any mortgage but rather be in 90p area than 65p. Given the current 400p forecast by end of year which is only 3.5 months away I am a bit disappointed but hey maybe O expected a little bit more.

[bones] 10/9/2018 13:19

Indeed ID.

[investordave] 10/9/2018 11:10

Nope. They can drop the share price as much as they like but they're not getting mine. All bought and paid for. Given how quickly the share price moves, you'd be mad to trade AOL on margin.